Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Graham

Showing results (171-180 of 206) with videos related to

Pageof 21
Sort By:
The Laryngoscope|September 13, 2000
Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathyH T Hoffman, J Quets, T Toshiaki, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 13, 2010
Oxygen is an essential medicine: a call for international actionT Duke, S M Graham, M N Cherian, et al.
Public Health Action|December 2, 2024
TB programme outcomes in South Fly District, Papua New Guinea, were maintained through COVID-19M Bauri, S Vaccher, T Marukutira, et al.
Head & Neck|October 28, 1998
Patterns of metastases to the upper jugular lymph nodes (the "submuscular recess")Y P Talmi, H T Hoffman, Z Horowitz, et al.
Psychology, Health & Medicine|November 24, 2018
Adjustment to acute or early HIV-1 infection diagnosis to prompt linkage to care and ART initiation: qualitative insights from coastal KenyaE M Van Der Elst, B Kombo, P Mugo, et al.
Sexually Transmitted Infections|May 22, 2009
A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in KenyaV Chohan, J M Baeten, S Benki, et al.
Leukemia|May 13, 2005
Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitroH G Jørgensen, E K Allan, S M Graham, et al.
Public Health Action|October 4, 2019
Drug-resistant tuberculosis diagnosis since Xpert<sup>®</sup> MTB/RIF introduction in Papua New Guinea, 2012-2017E K Lavu, K Johnson, J Banamu, et al.
Public Health Action|October 4, 2019
Outcomes in children treated for tuberculosis with the new dispersible fixed-dose combinations in Port MoresbyV Apis, M Landi, S M Graham, et al.
Oncogene|May 18, 1995
Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformationJ M Carboni, N Yan, A D Cox, et al.
Pageof 21

Showing results (171-180 of 206) with videos related to

Sort By:
Pageof 21
The Laryngoscope|September 13, 2000
Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathyH T Hoffman, J Quets, T Toshiaki, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 13, 2010
Oxygen is an essential medicine: a call for international actionT Duke, S M Graham, M N Cherian, et al.
Public Health Action|December 2, 2024
TB programme outcomes in South Fly District, Papua New Guinea, were maintained through COVID-19M Bauri, S Vaccher, T Marukutira, et al.
Head & Neck|October 28, 1998
Patterns of metastases to the upper jugular lymph nodes (the "submuscular recess")Y P Talmi, H T Hoffman, Z Horowitz, et al.
Psychology, Health & Medicine|November 24, 2018
Adjustment to acute or early HIV-1 infection diagnosis to prompt linkage to care and ART initiation: qualitative insights from coastal KenyaE M Van Der Elst, B Kombo, P Mugo, et al.
Sexually Transmitted Infections|May 22, 2009
A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in KenyaV Chohan, J M Baeten, S Benki, et al.
Leukemia|May 13, 2005
Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitroH G Jørgensen, E K Allan, S M Graham, et al.
Public Health Action|October 4, 2019
Drug-resistant tuberculosis diagnosis since Xpert<sup>®</sup> MTB/RIF introduction in Papua New Guinea, 2012-2017E K Lavu, K Johnson, J Banamu, et al.
Public Health Action|October 4, 2019
Outcomes in children treated for tuberculosis with the new dispersible fixed-dose combinations in Port MoresbyV Apis, M Landi, S M Graham, et al.
Oncogene|May 18, 1995
Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformationJ M Carboni, N Yan, A D Cox, et al.
Pageof 21